<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Genome Med</journal-id>
    <journal-id journal-id-type="iso-abbrev">Genome Med</journal-id>
    <journal-title-group>
      <journal-title>Genome Medicine</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1756-994X</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9987115</article-id>
    <article-id pub-id-type="publisher-id">1162</article-id>
    <article-id pub-id-type="doi">10.1186/s13073-023-01162-x</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Influence network model uncovers relations between biological processes and mutational signatures</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Amgalan</surname>
          <given-names>Bayarbaatar</given-names>
        </name>
        <address>
          <email>bayarbaatar.amgalan@hih.gov</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wojtowicz</surname>
          <given-names>Damian</given-names>
        </name>
        <address>
          <email>d.wojtowicz@mimuw.edu.pl</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Kim</surname>
          <given-names>Yoo-Ah</given-names>
        </name>
        <address>
          <email>yooah.kim@gmail.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" equal-contrib="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6261-277X</contrib-id>
        <name>
          <surname>Przytycka</surname>
          <given-names>Teresa M.</given-names>
        </name>
        <address>
          <email>przytyck@ncbi.nlm.nih.gov</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.419234.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 0604 5429</institution-id><institution>National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, </institution></institution-wrap>8600 Rockville Pike, 20894 Bethesda, USA </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.12847.38</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 1290</institution-id><institution>Current address: Faculty of Mathematics, Informatics, and Mechanics, University of Warsaw, </institution></institution-wrap>ul. Banacha 2, 02-097 Warszawa, Poland </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>6</day>
      <month>3</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>6</day>
      <month>3</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2023</year>
    </pub-date>
    <volume>15</volume>
    <elocation-id>15</elocation-id>
    <history>
      <date date-type="received">
        <day>31</day>
        <month>8</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>8</day>
        <month>2</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">There has been a growing appreciation recently that mutagenic processes can be studied through the lenses of mutational signatures, which represent characteristic mutation patterns attributed to individual mutagens. However, the causal links between mutagens and observed mutation patterns as well as other types of interactions between mutagenic processes and molecular pathways are not fully understood, limiting the utility of mutational signatures.</p>
      </sec>
      <sec>
        <title>Methods</title>
        <p id="Par2">To gain insights into these relationships, we developed a network-based method, named <sc>GeneSigNet</sc> that constructs an influence network among genes and mutational signatures. The approach leverages sparse partial correlation among other statistical techniques to uncover dominant influence relations between the activities of network nodes.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par3">Applying <sc>GeneSigNet</sc> to cancer data sets, we uncovered important relations between mutational signatures and several cellular processes that can shed light on cancer-related processes. Our results are consistent with previous findings, such as the impact of homologous recombination deficiency on clustered APOBEC mutations in breast cancer. The network identified by <sc>GeneSigNet</sc> also suggest an interaction between APOBEC hypermutation and activation of regulatory T Cells (Tregs), as well as a relation between APOBEC mutations and changes in DNA conformation. <sc>GeneSigNet</sc> also exposed a possible link between the SBS8 signature of unknown etiology and the Nucleotide Excision Repair (NER) pathway.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par4"><sc>GeneSigNet</sc> provides a new and powerful method to reveal the relation between mutational signatures and gene expression. The <sc>GeneSigNet</sc> method was implemented in python, and installable package, source codes and the data sets used for and generated during this study are available at the Github site <ext-link ext-link-type="uri" xlink:href="https://github.com/ncbi/GeneSigNet.">https://github.com/ncbi/GeneSigNet.</ext-link></p>
      </sec>
      <sec>
        <title>Supplementary Information</title>
        <p>The online version contains supplementary material available at 10.1186/s13073-023-01162-x.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Mutational signatures</kwd>
      <kwd>Networks</kwd>
      <kwd>Causality inference</kwd>
      <kwd>Mutational processes in cancer</kwd>
      <kwd>Breast cancer</kwd>
      <kwd>APOBEC</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Intramural Research Program of the National Library of Medicine at the National Institutes of Health, USA</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>National Institutes of Health (NIH)</institution>
        </funding-source>
      </award-group>
      <open-access>
        <p>Open Access funding provided by the National Institutes of Health (NIH)</p>
      </open-access>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2023</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par5">Traditionally, research in cancer genomics has been focused on the identification of cancer driving mutations that confer a growth advantage to cancer cells. However, since cancer often emerges as a byproduct of various mutagenic processes such as UV light or a faulty DNA repair mechanism, cancer genomes also accumulate numerous mutations with seemingly no direct roles in carcinogenesis. Different mutagenic processes often lead to distinct patterns of somatic mutations called <italic>mutational signatures</italic>. This provides an opportunity to leverage such signatures for studying interactions between mutagenic processes and other cellular process.</p>
    <p id="Par6">Starting from the pioneering work of Alexandrov et al. [<xref ref-type="bibr" rid="CR1">1</xref>], several computational methods have been developed to infer mutational signatures. The exposure of a genome to a given mutagenic process is measured by the number of mutations attributed to the corresponding signature. While the relations between some of these computationally-derived signatures and mutational processes causing them could be established based on prior knowledge or association with specific environmental or molecular factors [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>], the etiology of many signatures remains unknown or not fully understood. Mutagenic processes can be caused by perturbations of molecular pathways, and vice verse, they can disrupt normal cell function. Therefore elucidating the relation between mutational processes and activities of molecular pathways is of fundamental importance for a better understanding of the etiology of mutagenic processes and their role in carcinogenesis. Gene expression provides the most accessible measurement of the activities of cellular processes. Therefore, we reasoned that interrogating the relation between gene expression and exposure of a mutational signature might provide important clues on both: the etiology of mutational signatures and on the impact of the corresponding mutational processes on cellular functions.</p>
    <p id="Par7">There are several know examples where deficiencies in the activities of some genes such as MUTYH [<xref ref-type="bibr" rid="CR4">4</xref>], ERCC2 [<xref ref-type="bibr" rid="CR5">5</xref>], MSH6 [<xref ref-type="bibr" rid="CR6">6</xref>], and FHIT [<xref ref-type="bibr" rid="CR7">7</xref>] have been linked to specific signatures. Extending this observation beyond individual genes, a recent study successfully linked exposures of mutational signatures to mutated subnetworks [<xref ref-type="bibr" rid="CR8">8</xref>]. In addition, a correlation between the expression of the APOBEC family of genes and the exposures of signatures SBS2 and SBS13 (so-called APOBEC mutational signatures) has frequently been observed [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Finally, a perturbation of some cellular processes such as DNA replication or repair are known to be mutagenic.</p>
    <p id="Par8">There are also many examples of the reverse relation. For instance, tobacco smoking is not only mutagenic but it is also believed to activate the immune response [<xref ref-type="bibr" rid="CR10">10</xref>]. Specific mutagenic processes are known to activate specific DNA repair pathways. In addition, a mutagenic process can cause a cancer-driving mutation [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref> which can, in turn, cause changes in gene expression.</p>
    <p id="Par9">Finally, mutagenic processes themselves have been known to interact with each other. For example, homologous recombination deficiency (HRD) is often accompanied by mutational signatures related to APOBEC activity [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR14">14</xref>].</p>
    <p id="Par10">Applying a clustering-based method to genome-wide expression and mutational signature data, Kim et al. identified coherently expressed groups of genes associated with specific combinations of mutational signatures, providing interesting insights regarding these signatures [<xref ref-type="bibr" rid="CR8">8</xref>]. However, while such cluster-based analysis can suggest associations between signature exposures and the activities of biological processes, it lacks the ability to provide more precise explanations.</p>
    <p id="Par11">To fill this gap, we introduce a network-based method, named <sc>GeneSigNet</sc> (<italic>Gene</italic> and <italic>Si</italic><italic><underline>g</underline></italic>nature Influence <italic>Net</italic>work Model), aiming to uncover interactions among mutagenic and cellular processes, and to provide insights into mutagenic processes underlying individual signatures. Utilizing gene expression and mutational signature data from cancer patients, <sc>GeneSigNet</sc> constructs a Gene-Signature Network (GSN) that represents asymmetric dependencies among two types of node entities — genes and MutStates. MutState nodes are in one-to-one correspondence with mutational signatures and each MutState represents an abstract (directly unobserved) cell state associated with the corresponding mutational signature (for a detailed description, see the “<xref rid="Sec9" ref-type="sec">Results</xref>” section: The GeneSigNet method). Both types of nodes have patient-specific activities: gene expression for nodes corresponding to genes and signature exposure for nodes corresponding to MutStates. <sc>GeneSigNet</sc> utilizes these activities to infer directed edges between nodes in the GSN (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). The interactions represented by these edges correspond to potentially indirect dependencies between activities of network nodes. Ideally, we would like to infer causal relationships between molecular activities and mutational signatures. However, in complex molecular systems, inferring causality is one of the most challenging open problems. In some settings, prior information about gene function (such as transcription factor versus potential target gene) or special type of data such as response to a perturbation of the expression of a gene can be leveraged to infer causality [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. In our setting, however, no perturbation data or prior knowledge is available, requiring <sc>GeneSigNet</sc> to rely solely on the observed activities of nodes and infer network edges representing the relations between the nodes and their dependency directions. While inferring directed influences without such additional information remains challenging, significant efforts have been made to identify the conditions where the direction of an influence can be inferred with a reasonable level of success. For example, independent component analysis-based method LiNGAM allows to discover the causal relations between non-Gaussian random variables when the number of variables is much smaller than the number of observations [<xref ref-type="bibr" rid="CR19">19</xref>]. A node-ordering heuristic, GeneNet [<xref ref-type="bibr" rid="CR20">20</xref>] constructs a directed acyclic causal network by first computing a partial correlation network and subsequently selecting directed edges from the network based on a multiple testing of standardized partial variances.<fig id="Fig1"><label>Fig. 1</label><caption><p>Gene-Signature Network (GSN). <bold>A</bold> GSN is a weighted-directed network consisting of two types of nodes: genes (green circles), and MutStates (orange ovals) corresponding to signatures. Edges of a GSN represent inferred influences and might be either positive (red) or negative (blue). <bold>B</bold> Edges of a GSN are inferred based on the activities of nodes (gene expression for genes and signature exposures for MutStates (top panel)). A directed edge from a gene to a MutState represents a putative influence from the gene to the MutState. Analogously, a directed edge from a MutState to a gene represents an inferred effect of the MutState on the gene. The thickness of the arrows reflects the edge weights</p></caption><graphic xlink:href="13073_2023_1162_Fig1_HTML" id="MO1"/></fig></p>
    <p id="Par12">Sparse estimation of partial correlations (SPCS) also builds on partial correlation relations, which computes a sparse asymmetric weight matrix representing directed influences among nodes in the network. The sparsity constraints ensure that only a small fraction of influential edges have nonzero weights while many entries of such inferred matrix are set to zero and one-directional [<xref ref-type="bibr" rid="CR21">21</xref>].</p>
    <p id="Par13">In contrast, the statistical higher moments were used as indicators of the direction of dependency between two variables [<xref ref-type="bibr" rid="CR22">22</xref>] under the assumption of absence of confounding effects.</p>
    <p id="Par14">The <sc>GeneSigNet</sc> method builds on the last two approaches. First, a sparse partial correlation technique (SPCS) is used to obtain an initial sparse weighted directed network. We opted to infer a sparse network in order to focus on strongest trends that are more likely to suggest mechanistic explanations. This initial network contains bidirectional edges. Next, where applicable, a novel partial higher moment strategy is used to resolve (orient) bidirectional edges. We note that <sc>GeneSigNet</sc> does not attempt to construct a fully resolved oriented graph, leaving many edges as bidirectional. We found that this approach compares favorably to the previously proposed techniques that can be used for this task.</p>
    <p id="Par15">We applied <sc>GeneSigNet</sc> to two cancer datasets, breast cancer and lung adenocarcinoma, for which sufficient numbers of patient samples with gene expression data are available and the interactions of mutational signatures are partially known. For the network reconstruction, we utilized genes in two GO categories: metabolism and immunity. It is increasingly appreciated that cellular metabolic regulation can lead to DNA damage and can impact DNA repair, stimulating interest in the understanding of the cross-talk between DNA-damage and metabolism [<xref ref-type="bibr" rid="CR23">23</xref>]. In addition, DNA damage response is known to interact with immune system and a better understanding of this interaction can guide cancer immunotherapy [<xref ref-type="bibr" rid="CR24">24</xref>]. Therefore to empower the method to gain more insights into these important interactions, we limited the set of nodes corresponding to genes to these two categories.</p>
    <p id="Par16">The relations inferred by the <sc>GeneSigNet</sc> model are overall consistent with current knowledge, but also include several interesting novel findings. In particular, the model suggests a causative relation from the homologous recombination deficiency signature (SBS3) to a clustered APOBEC mutation signature, and also linked Signature 8 (SBS8) to nucleotide excision repair (NER) pathway. The latter connection is consistent with the recent findings based on an experimental study in mouse [<xref ref-type="bibr" rid="CR25">25</xref>]. In addition, <sc>GeneSigNet</sc> identified a novel relation between APOBEC hypermutation and the activation of regulatory T cells which presents an important implication in immunotherapy, and captured a relation of APOBEC signature (SBS2) with DNA conformation changes among other findings. Taken together, our results demonstrate that <sc>GeneSigNet</sc> provides novel and important insights.</p>
  </sec>
  <sec id="Sec2">
    <title>Methods</title>
    <sec id="Sec3">
      <title>The <sc>GeneSigNet</sc> method</title>
      <sec id="Sec4">
        <title>Gene-Signature Network</title>
        <p id="Par17">The main idea behind <sc>GeneSigNet</sc> is a construction of a Gene-Signature Network (GSN) consisting of two types of nodes: nodes corresponding to genes, and nodes corresponding to mutational signatures (Fig. <xref rid="Fig1" ref-type="fig">1</xref>A). Patient-specific activity of a node corresponding to a gene is measured by gene expression. The exposure of a mutational signature can be seen as a measure of the activity of the corresponding mutagenic process, such as an exogenous mutagen, or the activity of a cellular process triggered in the response to a mutagen. This motivates the concept of <italic>MutState</italic> defined as an abstract representation of the process(es) effectuating a mutational signature. The activity of this state is measured as the exposure of the corresponding mutational signature in the given patient. Statistical relations on the activities of genes and MutStates are likely to shed light on the genes and pathways associated with, and potentially contributing to, the level of the exposure of the corresponding mutational signature. To this end, <sc>GeneSigNet</sc> infers directed edges between both types of nodes, utilizing patient-specific gene expression (for genes) and exposures of mutational signatures (for MutStates) as described below (Fig. <xref rid="Fig1" ref-type="fig">1</xref>B). Other than the difference in the definitions of node activities (and the subsequent interpretation), the network inference algorithm does not distinguish between the two types of nodes.</p>
      </sec>
      <sec id="Sec5">
        <title>A high level description of the GeneSigNet inference method</title>
        <p id="Par18"><sc>GeneSigNet</sc> method constructs GSN in two main steps: (i) constructing a preliminary directed network using a sparse partial correlation selection (SPCS), and (ii) revising the initial network by testing whether the orientation of bidirectional edges can be decided using a partial higher moment strategy adapted to a network setting. The workflow of the <sc>GeneSigNet</sc> method is shown in Fig. <xref rid="Fig2" ref-type="fig">2</xref>.<fig id="Fig2"><label>Fig. 2</label><caption><p>Workflow of <sc>GeneSigNet</sc>. <bold>A</bold> Input matrix <italic>X</italic> of node activities constructed by concatenating gene expression values (for genes) and signature exposures (for MutStates) across <italic>p</italic> samples (patients). <bold>B</bold> Given the input matrix <italic>X</italic>, we infer a network of <italic>n</italic> nodes. For each node, Sparse Partial Correlation Selection (SPCS) is used to simultaneously estimate the weights of incoming effects from the other <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n-1$$\end{document}</tex-math><mml:math id="M2"><mml:mrow><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="13073_2023_1162_Article_IEq1.gif"/></alternatives></inline-formula> nodes. <bold>C</bold> For each bidirectional edge (<italic>j</italic>, <italic>f</italic>), the residual vectors <inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$r_j$$\end{document}</tex-math><mml:math id="M4"><mml:msub><mml:mi>r</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="13073_2023_1162_Article_IEq2.gif"/></alternatives></inline-formula> and <inline-formula id="IEq3"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$r_f$$\end{document}</tex-math><mml:math id="M6"><mml:msub><mml:mi>r</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="13073_2023_1162_Article_IEq3.gif"/></alternatives></inline-formula> corresponding to nodes <italic>j</italic> and <italic>f</italic> are obtained by removing effects of the <inline-formula id="IEq4"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n-2$$\end{document}</tex-math><mml:math id="M8"><mml:mrow><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="13073_2023_1162_Article_IEq4.gif"/></alternatives></inline-formula> nodes other than the two nodes of the considered edge. The non-zero weight <inline-formula id="IEq5"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$w_{kf}$$\end{document}</tex-math><mml:math id="M10"><mml:msub><mml:mi>w</mml:mi><mml:mrow><mml:mi mathvariant="italic">kf</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="13073_2023_1162_Article_IEq5.gif"/></alternatives></inline-formula> obtained by SPCS denotes the strength of the confounding effect on node <italic>f</italic> coming from node <italic>k</italic>. The direction of a influence effect between the pair of nodes is determined based on the partial higher moment statistics, skewness and kurtosis of residuals <inline-formula id="IEq6"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$r_j$$\end{document}</tex-math><mml:math id="M12"><mml:msub><mml:mi>r</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="13073_2023_1162_Article_IEq6.gif"/></alternatives></inline-formula> and <inline-formula id="IEq7"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$r_f$$\end{document}</tex-math><mml:math id="M14"><mml:msub><mml:mi>r</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="13073_2023_1162_Article_IEq7.gif"/></alternatives></inline-formula>. If both moments support the same direction with the heavier partial correlation weight (see Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Equation S5), then the edge corresponding to the opposite direction is removed, otherwise, both edges remain in the network. <bold>D</bold> Edge weights are normalized using an alternative scaling algorithm, and the final weighted-directed network is obtained as the output</p></caption><graphic xlink:href="13073_2023_1162_Fig2_HTML" id="MO2"/></fig></p>
        <p id="Par19">In the first step, given the input matrix describing the activities of genes and MutStates across samples, <sc>GeneSigNet</sc> constructs an initial weighted-directed graph using a sparse partial correlation selection (SPCS) (Fig. <xref rid="Fig2" ref-type="fig">2</xref>B). Specifically, considering each node as a target, <sc>GeneSigNet</sc> uses SPCS to compute the weights of incoming effects from the other <inline-formula id="IEq8"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n-1$$\end{document}</tex-math><mml:math id="M16"><mml:mrow><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="13073_2023_1162_Article_IEq8.gif"/></alternatives></inline-formula> nodes. This SPCS step builds on the fact that partial correlations can be approximated by sparse regression coefficients and utilizes a constraint on the <inline-formula id="IEq9"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$l_1$$\end{document}</tex-math><mml:math id="M18"><mml:msub><mml:mi>l</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13073_2023_1162_Article_IEq9.gif"/></alternatives></inline-formula> norm enforcing the weights of the incoming edges to provide a sparse solution while avoiding over-fitting (see Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Sections S1.1 and S1.2, for a detailed description). Sparse correlation techniques lead to a construction of a “sparse” network focusing on the strongest trends that are easier to interpret and are more likely to suggest mechanistic explanations although this is done at the cost of a potential loss of some information (for more discussions, see the “<xref rid="Sec20" ref-type="sec">Discussion</xref>” section). We note that since SPCS is applied to each node separately, <sc>GeneSigNet</sc> ensures a locally-sparse solution, rather than constraining the network edges globally.</p>
        <p id="Par20">In the second step, <sc>GeneSigNet</sc> refines the initial network by reducing the number of bidirectional edges remaining after the first step. The idea is an adaptation of the basic bivariate higher moment strategy to multivariate analysis. Specifically, for any two nodes having potential effects on each other in the initial network (endpoints of a bidirectional edge), we first utilize the partial correlation technique to remove confounding effects due to the presence of the other <inline-formula id="IEq10"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n-2$$\end{document}</tex-math><mml:math id="M20"><mml:mrow><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="13073_2023_1162_Article_IEq10.gif"/></alternatives></inline-formula> variables from the observed activities of the two nodes and obtain the residuals representing the remaining dependencies between the pair [<xref ref-type="bibr" rid="CR26">26</xref>]. Under the assumption that all confounding effects due to the presence of the other <inline-formula id="IEq11"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n-2$$\end{document}</tex-math><mml:math id="M22"><mml:mrow><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="13073_2023_1162_Article_IEq11.gif"/></alternatives></inline-formula> variables were successfully removed by partial correlation, the influence variable may be distinguished from the affected variable by comparing the higher moments of the two residual distributions. Specifically, the affected variable is expected to be closer to normality than the influence factor, and the skewness and kurtosis are the higher moment statistics used to measure the close-normality of distributions. We refer to this strategy as <italic>partial higher moment strategy</italic>.</p>
        <p id="Par21">We note that the method relies on simplifying assumptions which might not be fully satisfied in real biologic relations. In particular, the assumption that all confounding effects come from the activities of the remaining <inline-formula id="IEq12"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n-2$$\end{document}</tex-math><mml:math id="M24"><mml:mrow><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="13073_2023_1162_Article_IEq12.gif"/></alternatives></inline-formula> nodes in the network is an oversimplification since in such complex systems, potential effects from unobserved latent factors are likely to be present. Thus, we next evaluated the performance of the method on simulated and real data (to the extent possible in the absence of the ground truth).</p>
        <p id="Par22">Figure <xref rid="Fig3" ref-type="fig">3</xref> provides a real example illustrating the necessity of removing confounding effects before applying the higher moment statistics to correctly indicate the influence direction. Before removing confounding effects, the two higher moment statistics supported contradictory directions (Fig. <xref rid="Fig3" ref-type="fig">3</xref>A). After removing the confounding effects, both statistics correctly indicate the influence direction [<xref ref-type="bibr" rid="CR27">27</xref>] (Fig. <xref rid="Fig3" ref-type="fig">3</xref>B). More examples based on experimentally confirmed regulatory directions [<xref ref-type="bibr" rid="CR27">27</xref>] are provided in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S2.<fig id="Fig3"><label>Fig. 3</label><caption><p>Basic higher moment statistics (<bold>A</bold>) versus the partial higher moment strategy (<bold>B</bold>). The experimentally confirmed regulatory relation is from CEBPB to MBD2. Using uncorrected moment statistics, the two higher moment statistics, skewness and kurtosis, support contradictory directions (<bold>A</bold>). The proposed partial higher-moment strategy predicts the correct direction (<bold>B</bold>). For each case, brown color indicates the higher value for a given moment</p></caption><graphic xlink:href="13073_2023_1162_Fig3_HTML" id="MO3"/></fig></p>
        <p id="Par23">Finally, alternate scaling [<xref ref-type="bibr" rid="CR28">28</xref>], a matrix normalization algorithm, is used to bring the total incoming and outgoing effects of each node into the same range (for details, see Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Section S1.4). A detailed description of <sc>GeneSigNet</sc> is provided in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Section S1.</p>
      </sec>
    </sec>
    <sec id="Sec6">
      <title>Materials</title>
      <sec id="Sec7">
        <title>Breast cancer data</title>
        <p id="Par24">The normalized gene expression data for 266 breast cancer (BRCA) patients were downloaded from Table S7 in [<xref ref-type="bibr" rid="CR29">29</xref>]. Gene expression profiles for 2,204 genes involved in either DNA metabolic or immune response processes of the Gene Ontology (GO) database were selected for the analysis.</p>
        <p id="Par25">For mutational signatures, somatic mutation data were downloaded from the ICGC data portal [<xref ref-type="bibr" rid="CR30">30</xref>]. The 3,479,652 point mutations were assigned to mutational signatures using <sc>SigMa</sc> [<xref ref-type="bibr" rid="CR9">9</xref>]. <sc>SigMa</sc> divided all mutations into two groups, close-by <italic>C</italic>lustered and <italic>D</italic>ispersed mutations, and assigned each of these mutations to one of 12 COSMIC v2 signatures [<xref ref-type="bibr" rid="CR31">31</xref>] which were previously identified as active in BRCA (Signatures 1, 2, 3, 5, 6, 8, 13, 17, 18, 20, 26, and 30). From the signatures classified by <sc>SigMa</sc> as described above, signature phenotype profiles 1D, 2C/D, 3C/D, 5D, 8C/D, and 13C/D that had exposure levels of at least 10% within each group were selected for further analysis (the numbering refers to the COSMIC signature index and C/D denotes signatures attributed to clustered and dispersed mutations). Examining their correlation patterns among patients, some of the signatures were grouped as follows: Signatures 3C/D and 8D were combined into DSB (double-stranded DNA break repair) related signatures, and Signatures 2C and 13C/D into APOBEC related signatures. The remaining signatures are treated separately, resulting in Signature 1, 2D, 5, APOBEC, DSB. A log transformation was consequently performed on exposures of each signature to make its distribution shape closer to a bell curve of normality.</p>
        <p id="Par26">Furthermore, we included binary information of homologous recombination deficiency as an additional variable in the analysis. The binary alteration information was obtained by aggregating functional inactivation information for BRCA1/BRCA2 and 16 other HR genes as provided in Supplementary Tables 4a and 4b of Davies et al. [<xref ref-type="bibr" rid="CR32">32</xref>]. The positive entries were assigned a real value of 4.218 in the SPCS model with the hyperparameter search for the best performance in terms of the means of minimum least square errors and maximum Pearson correlation between responses and predictions over all nodes.</p>
      </sec>
      <sec id="Sec8">
        <title>Lung adenocarcinoma data</title>
        <p id="Par27">The expression data (RNA-seq) of the lung adenocarcinoma (LUAD) from The Cancer Genome Atlas (TCGA) project were downloaded from the Genomic Data Commons Data Portal on 2020-06-05 [<xref ref-type="bibr" rid="CR33">33</xref>]. Normalization and variance-stabilizing transformation (vst) of HTSeq count data were performed using DESeq2. Tumor and normal samples were split into different groups and only one sample per donor was kept in each group.</p>
        <p id="Par28">The TCGA LUAD exome mutation spectra were downloaded from Synapse [<xref ref-type="bibr" rid="CR34">34</xref>] and decomposed into COSMIC v3 signatures SBS1, SBS2, SBS4, SBS5, SBS13, SBS40, and SBS45 using the quadratic programming (QP) approach available in the R package SignatureEstimation [<xref ref-type="bibr" rid="CR35">35</xref>]. Only signatures predominantly active in lung cancer (signatures that were present in at least 5% of samples and were responsible for at least 1% of mutations) were considered based on the initial sample decomposition provided by Alexandrov et al. [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. Signature SBS45 is likely a sequencing artifact so it was omitted from further analyses presented in this study. The same log transformation used in BRCA analysis was performed on signature exposure data as well.</p>
        <p id="Par29">We analyzed 466 tumor samples that had both gene expression and mutational signature exposure data available. We analyzed 2433 genes belonging to the DNA metabolic process and immune system process in GO terms (genes that are not expressed in at least 10% of the samples were omitted). The gene expression and mutational signature exposure data were combined to form an input data matrix. All the data is available at the Github site <ext-link ext-link-type="uri" xlink:href="https://github.com/ncbi/GeneSigNet">https://github.com/ncbi/GeneSigNet</ext-link> [<xref ref-type="bibr" rid="CR37">37</xref>].</p>
        <p id="Par30">The numbers of recovered edges and average degrees for each of the two cancer networks are summarized in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1.</p>
      </sec>
    </sec>
  </sec>
  <sec id="Sec9">
    <title>Results</title>
    <sec id="Sec10">
      <title>Performance evaluation for <sc>GeneSigNet</sc></title>
      <sec id="Sec11">
        <title>Evaluation of the method on simulated data</title>
        <p id="Par31"><sc>GeneSigNet</sc> infers a directed network representing information flow between genes’ expression and signatures’ exposure. We compared the performance of <sc>GeneSigNet</sc> to four competing approaches which, similarly to <sc>GeneSigNet</sc>, strive to predict influence flow between network nodes. We compare <sc>GeneSigNet</sc> to the following key approaches: (1) the independent component analysis-based method LiNGAM [<xref ref-type="bibr" rid="CR19">19</xref>], (2) the partial correlation-based heuristic GeneNet [<xref ref-type="bibr" rid="CR20">20</xref>] previously proposed to discover the causal structure in high-dimensional genomic data [<xref ref-type="bibr" rid="CR21">21</xref>], (3) the Sparse Partial Correlation Selection (SPCS) approach [<xref ref-type="bibr" rid="CR21">21</xref>] and (4) ElasticNet [<xref ref-type="bibr" rid="CR38">38</xref>]. Additionally, we included (5) the regression tree-based approach used by GENIE3 method [<xref ref-type="bibr" rid="CR39">39</xref>] for the inference of Gene Regulatory Networks (GRN)  [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. We note that the task of GRN inference is different from inferring influence graphs considered in this study. However, since the method produces a fully connected directed weighted graph we used a procedure that reduces bidirectional edges to oriented edges by retaining the heavier edge in the pair. Since GENIE3 is the winning gene expression-based GRN reconstruction method [<xref ref-type="bibr" rid="CR42">42</xref>], this allowed us to test if a basic adaptation of a GRN reconstruction method can provide a competitive solution to our problem.</p>
        <p id="Par32">To generate data, we implemented the data simulation schema provided in LiNGAM [<xref ref-type="bibr" rid="CR19">19</xref>]. This approach starts with the construction of a lower triangular weight matrix representing the directed weighted interactions among the nodes (random variables) in a directed acyclic graph (DAG). This matrix is then used as the representation of the dependency patterns in the generation of the data set (for detailed description of the data generation, see Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Section S1.5). We simulated a set for 100 random variables (nodes) with 1000 samples from multivariate distributions. The weight matrix used in the simulation contains 364 directed edges.</p>
        <p id="Par33">The performances of the methods are summarized in Fig. <xref rid="Fig4" ref-type="fig">4</xref>. <sc>GeneSigNet</sc>, GeneNet, LiNGAM, SPCS and ElasticNet construct a single network that is the output of the method-specific optimization procedure, thus their performances are represented by single points in Fig. <xref rid="Fig4" ref-type="fig">4</xref>A. The outcome of the regression tree approach can be defined differently depending on edge-weight cut-offs and its performance is thus represented by a set of points for various cut-offs. The results were similar for all cut-offs and for the remaining measures we report a representative result corresponding to 520 edges (big green triangle in Fig. <xref rid="Fig4" ref-type="fig">4</xref>A). <sc>GeneSigNet</sc> had the highest precision in predicting the direction of the influence. The F-score (the harmonic mean of precision and recall), was also the highest for <sc>GeneSigNet</sc> although only slightly better than the second best method, GeneNet. In addition, we also evaluated the methods on their ability to recover the values of the lower triangular matrix used to simulate the data. This measure was proposed in [<xref ref-type="bibr" rid="CR19">19</xref>] and measures the correlation between edge weights used for the simulation and weights recovered by the algorithm. Despite inferring a smaller number of edges the <sc>GeneSigNet</sc>’ ability to reconstruct the input matrix was equal or better relative to other methods, suggesting that <sc>GeneSigNet</sc> indeed captured dominating influences using a smaller number of edges.<fig id="Fig4"><label>Fig. 4</label><caption><p>Evaluation of the results on simulated data. In <bold>A</bold>, the horizontal axis denotes the number of selected edges in the prediction. The vertical axis denotes the precision of the compared methods. In <bold>B</bold>, we report comparisons based on F-score, ability to reproduce the influence weight values used to generate the simulation data (correlation), and the number of the inferred edges</p></caption><graphic xlink:href="13073_2023_1162_Fig4_HTML" id="MO4"/></fig></p>
      </sec>
      <sec id="Sec12">
        <title>Evaluation of the directionality inference on real cancer data</title>
        <p id="Par34">We also compared the performance of the methods on breast cancer (BRCA) and lung cancer (LUAD) data sets (for details, see the “<xref rid="Sec7" ref-type="sec">Materials</xref>” section). The LiNGAM method was excluded from this evaluation, since it cannot deal with large genome-wide datasets. In this setting the true direction of most of the inferred edges is, unfortunately, unknown. Therefore, we leverage the fact that if a method infers a relation between a transcription factor (TF) and a target gene (TG) then the edge should be directed from TF to TG (under the assumption that TG is not a TF). Leveraging this principle, we evaluated the precision of the directionality inference utilising the ChEA database containing directed protein-DNA interactions [<xref ref-type="bibr" rid="CR27">27</xref>]. Specifically, for each method, we used the set of ChEA edges that overlap with the edges inferred by the method. Since the number of edges overlapping with ChEA set was different in each experiment, we used the percentage of overlap as the reference to ensure fairness of the comparison (horizontal axis in Fig. <xref rid="Fig5" ref-type="fig">5</xref>). <sc>GeneSigNet</sc> had the highest precision. Surprisingly, GeneNet and the regression tree methods resulted in worse than random performance in the evaluation on the BRCA data. Unfortunately, in the case of real data, the weights of the reference edges are unknown so we do not have a measure corresponding to the correlation function used on simulated data.<fig id="Fig5"><label>Fig. 5</label><caption><p>Correctness evaluation of directionality inference on real data sets. In <bold>A</bold>, the horizontal axis denotes the percent of ChEA edges for which a method made a prediction (out of all ChEA edges recovered by the method) whereas the vertical axis denotes the fraction of correctly predicted directions for these edges. In <bold>B</bold>, we provide the numerical values of the results visualized in <bold>A</bold></p></caption><graphic xlink:href="13073_2023_1162_Fig5_HTML" id="MO5"/></fig></p>
        <p id="Par35">Overall the relations between the methods’ performances observed in this evaluation were very similar to the trends observed on simulated data supporting the choice of our network reconstruction strategy.</p>
        <p id="Par36">Finally, we tested the robustness of our new partial higher moment strategy used in the second step of <sc>GeneSigNet</sc>, by performing a bootstrap sampling which is described in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Section S1.3. The approach was highly reproducible as summarized in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Section S1.3 and Fig. S1. <sc>GeneSigNet</sc> compared favorably to the competing approaches.</p>
        <p id="Par37">The <sc>GeneSigNet</sc> method was implemented in python, and installable package, source codes and the data sets used for and generated during this study are available at the Github site <ext-link ext-link-type="uri" xlink:href="https://github.com/ncbi/GeneSigNet">https://github.com/ncbi/GeneSigNet</ext-link> [<xref ref-type="bibr" rid="CR37">37</xref>].</p>
      </sec>
    </sec>
    <sec id="Sec13">
      <title>Analysis of the relations between mutational signatures and molecular pathways in breast cancer</title>
      <p id="Par38">We utilized breast cancer (BRCA) data collection obtained from ICGC which includes 266 cancer samples providing both whole-genome sequencing data and gene expression data (for details, see the “<xref rid="Sec7" ref-type="sec">Materials</xref>” section: Breast cancer data). The breast cancer genomes harbor mutations mainly contributed by 6 COSMIC mutational signatures — SBS1, 2, 3, 5, 8, and 13. We further refined the mutational signatures based on mutation density and sample correlations. The mutations in BRCA are characterized by occurrences of short highly mutated regions whose origin is believed to be different compared to sparse mutations [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. The information available from whole-genome sequencing allows for distinguishing these two types of mutation patterns and to treat such dense and sparse mutation regions differently. The post-processing of mutational signatures resulted in 6 signature groups that we use for subsequent analysis to construct the GSN – SBS1, <sc>APOBEC-C</sc> (clustered SBS2 and SBS13 corresponding to APOBEC hypermutation), <sc>APOBEC-D</sc> (SBS2 corresponding to disperse APOBEC mutations), DSB (SBS3 and clustered SBS8), SBS5, and SBS8D (dispersed SBS8). In addition to gene expressions and exposures of mutational signatures, we included a node indicating the binary status of homologous recombination deficiency (HRD) as it is assumed to lead to specific patterns of mutational signatures in BRCA [<xref ref-type="bibr" rid="CR32">32</xref>]. We applied <sc>GeneSigNet</sc> to construct a GSN for genes, mutational signatures, and HRD status, and to find relations between these features.</p>
      <sec id="Sec14">
        <title>Consistency of GeneSigNet results with current knowledge</title>
        <p id="Par39">Many relations uncovered with <sc>GeneSigNet</sc> are consistent with our current knowledge on mutational signatures, confirming the validity of our method. In particular, it is well appreciated that homologous recombination (HR) plays an important role in the double-strand break (DSB) repair mechanism and that HR deficiency is associated with the DSB signature [<xref ref-type="bibr" rid="CR46">46</xref>]. Indeed, our network correctly predicted a strong positive influence from HRD status to the DSB signature (Fig. <xref rid="Fig6" ref-type="fig">6</xref>). In addition, <sc>GeneSigNet</sc> identified the known negative impact of BRCA1 expression on the DSB signature which is also consistent with the role of BRCA1 in HRD [<xref ref-type="bibr" rid="CR46">46</xref>]. Furthermore, <sc>GeneSigNet</sc> captured the impact of HRD on chromosome separation, reflecting the role of homologous recombination in maintaining genomic stability [<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR48">48</xref>], and identified the association of <sc>APOBEC-D</sc> with telomere maintenance, consistent with the well recognized role of APOBEC mutagenesis in replication [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>].<fig id="Fig6"><label>Fig. 6</label><caption><p>Subnetworks of GSN for BRCA centered on (induced by) MutStates associated with Homologous Recombination, APOBEC and SBS8. Edge and node colors are as in Fig. <xref rid="Fig1" ref-type="fig">1</xref>. In boxes, there are the names of the genes adjacent to a given MutState with edge weight cut-off (<inline-formula id="IEq13"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$|w_{ij}|\ge 0.01$$\end{document}</tex-math><mml:math id="M26"><mml:mrow><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:msub><mml:mi>w</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo>≥</mml:mo><mml:mn>0.01</mml:mn></mml:mrow></mml:mrow></mml:math><inline-graphic xlink:href="13073_2023_1162_Article_IEq13.gif"/></alternatives></inline-formula>). The genes in bold are discussed in more detail in the text and the genes having bidirected interactions with MutStates are underlined. If the adjacent genes are enriched with specific GO pathways (<inline-formula id="IEq14"><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$q-value&lt;0.01$$\end{document}</tex-math><mml:math id="M28"><mml:mrow><mml:mi>q</mml:mi><mml:mo>-</mml:mo><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>e</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.01</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="13073_2023_1162_Article_IEq14.gif"/></alternatives></inline-formula>) then only the pathway genes are provided in the box. The HRD status dominantly contributes to the mutation strength in the DSB repair MutState. Increased DSB exposure leads to an increase of the exposures of <sc>APOBEC-C</sc> and (indirectly) <sc>APOBEC-D</sc> MutStates. SBS8 mutations are linked to the deficiency of nucleotide excision repair. The thickness of the arrows represents the edge weight (average edge weight if multiple genes are in a box). An extended subnetwork including all MutStates and an extended list of genes, and GO-terms are provided in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S3, Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S2, and Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Table S4</p></caption><graphic xlink:href="13073_2023_1162_Fig6_HTML" id="MO6"/></fig></p>
        <p id="Par40">Interestingly, our method linked SBS8 to the nucleotide excision repair (NER) pathway (Fig. <xref rid="Fig6" ref-type="fig">6</xref>). The etiology of this signature has remained unknown until a recent experimental study linked it to the NER pathway as well [<xref ref-type="bibr" rid="CR25">25</xref>]. This demonstrates the power of the <sc>GeneSigNet</sc> method to uncover non-obvious relationships.</p>
      </sec>
      <sec id="Sec15">
        <title>Untangling the interactions between APOBEC and DSB processes</title>
        <p id="Par41">Previous studies speculated that APOBEC related mutational signatures can arise in multiple different scenarios. First, double-strand breaks (DSB) created by the homologous recombination deficiency (HRD) provide mutational opportunities for APOBEC enzymes to act on the ssDNA regions, resulting in clustered APOBEC mutations [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]. In another scenario, a recent study attributed APOBEC-mediated hypermutations to the normal activity of mismatch repair which also involves creating ssDNA regions, generating “fog” APOBEC mutations [<xref ref-type="bibr" rid="CR44">44</xref>]. The complex interplay between APOBEC activities and other DNA repair mechanisms is yet to be elucidated.</p>
        <p id="Par42">Focusing on the interactions of APOBEC signatures with the other MutStates and genes, we observe that <sc>GeneSigNet</sc> supports a positive influence of the DSB on <sc>APOBEC-C</sc> MutState, consistent with the assumption that double-strand breaks provide an opportunity for APOBEC mutations. Additionally, our analysis reveals that the expression level of the APOBEC3B enzyme is associated with the strength of the DSB signature. Indeed, a previous study proposed that APOBEC3 proteins are recruited to DSB sites to participate in the DSB repair process [<xref ref-type="bibr" rid="CR14">14</xref>]. Thus, DSB contributes to an increase in <sc>APOBEC-C</sc> strength by two different mechanisms: (i) increased mutation opportunity due to ssDNA created by DSB and (ii) increased mutation probability due to increased APOBEC3B expression. Note that increased APOBEC expression would also increase APOBEC mutations in the “fog” regions proposed in [<xref ref-type="bibr" rid="CR44">44</xref>].</p>
        <p id="Par43">On the other hand, the activity of <sc>APOBEC-D</sc> is positively influenced by <sc>APOBEC-C</sc> activity, without direct relation to DSB. In fact, <sc>GeneSigNet</sc> inferred a negative influence from HR status to <sc>APOBEC-D</sc> MutState, confirming that different mutagenic processes are involved in clustered and dispersed APOBEC mutations (Fig. <xref rid="Fig6" ref-type="fig">6</xref>).</p>
      </sec>
      <sec id="Sec16">
        <title>APOBEC hypermutation activates regulatory T cells — implications for immunotherapy</title>
        <p id="Par44">Interestingly, GO enrichment analysis of the genes associated with APOBEC mutational signatures (genes influenced by <sc>APOBEC-C</sc> MutState) revealed significant enrichment in positive regulation of regulatory T cells (Tregs) differentiation (Fig. <xref rid="Fig6" ref-type="fig">6</xref>). Tregs, a subtype of T cells that suppress the immune response, are important for maintaining cell homeostasis and self-tolerance but can also interfere with anti-tumor immune response [<xref ref-type="bibr" rid="CR53">53</xref>]. The top three genes (FOXP3, BCL6, and LILRB2) positively influenced by <sc>APOBEC-C</sc> signature are all related to such inhibitory mechanism to immune response [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. FOXP3 is a transcriptional regulator playing a crucial role in the inhibitory function of Tregs. BCL6 is also essential for the stability of Tregs that promotes tumor growth. LILRB2 is a receptor for class I MHC antigens and is involved in the down-regulation of the immune response and the development of immune tolerance.</p>
        <p id="Par45">Our results help to understand a complicated role of APOBEC mutagenesis holds for immunotherapy. For example, patients with cancers displaying a high mutation burden are likely to produce tumor-associated neoantigens (mutated peptides presented at their surface) allowing them to benefit from immunotherapy [<xref ref-type="bibr" rid="CR57">57</xref>]. In particular, the APOBEC mutational signature was identified as a potential predictive marker for immunotherapy response in some cancers [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>]. Yet, cells carrying a high mutation burden often develop mechanisms of immune tolerance involving activation of Tregs to protect themselves from the destruction [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>]. Consequently, observed increased number of Tregs in response to high APOBEC mutations may lead to resistance to immune checkpoint inhibitors [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. Thus, our finding suggests that a combined strategy targeting Tregs in addition to immune checkpoint inhibitors would be most beneficial for a better outcome in APOBEC hypermutated breast cancer tumors.</p>
      </sec>
    </sec>
    <sec id="Sec17">
      <title>Analysis of the relations between mutational signatures and molecular pathways in Lung Adenocarcinoma</title>
      <p id="Par46">We next analyzed lung adenocarcinoma (LUAD) data using 466 cancer samples from the TCGA project. The exposure levels of 6 COSMIC mutational signatures (SBS1, 2, 4, 5, 13, and 40) present in the exome sequencing data were integrated with the RNAseq expression data of 2433 genes belonging to the DNA metabolic and immune system processes in Gene Ontology terms to uncover influence between signatures and genes (for details, see the “<xref rid="Sec7" ref-type="sec">Materials</xref>” section: Lung adenocarcinoma data).</p>
      <sec id="Sec18">
        <title>GeneSigNet uncovers immune response due to smoking</title>
        <p id="Par47">Two prominent mutational signatures in LUAD, SBS4 and SBS5, are assumed to result from exogenous causes [<xref ref-type="bibr" rid="CR8">8</xref>]. SBS4 is associated specifically with exposure to cigarette smoking in lungs. SBS5 is known to accompany the smoking signature but it is also present in many other cancer types. Previous studies suggested that cigarette smoking stimulates an inflammatory response [<xref ref-type="bibr" rid="CR10">10</xref>]. Consistent with these findings, the genes identified by <sc>GeneSigNet</sc> as influenced by SBS4 and SBS5 MutStates are indeed enriched with immune response genes (Fig. <xref rid="Fig7" ref-type="fig">7</xref>).<fig id="Fig7"><label>Fig. 7</label><caption><p>Subnetwork of LUAD GSN centered on MutStates known to be related to smoking and APOBEC. The meaning of colors and boxes is the same as in Figs. <xref rid="Fig1" ref-type="fig">1</xref> and <xref rid="Fig6" ref-type="fig">6</xref>. An extended subnetwork including all MutStates and an extended list of genes, and GO-terms are provided in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S4, Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S3, and Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Table S5</p></caption><graphic xlink:href="13073_2023_1162_Fig7_HTML" id="MO7"/></fig></p>
        <p id="Par48"><sc>GeneSigNet</sc> also identified the influence of the signatures SBS4 and SBS5 on two APOBEC signatures — SBS2 and SBS13. The APOBEC signatures are associated with immune response and this relationship is consistent with the previously proposed immune activation due to smoking exposure [<xref ref-type="bibr" rid="CR64">64</xref>]. In addition, <sc>GeneSigNet</sc> correctly captured the association of SBS13 (consequently SBS2) with the expressions of APOBEC3B and APOBEC3A enzymes, and also identified the association of SBS13 with pyrimidine related catabolic processes, potentially reflecting the fact that SBS13 involves a pyrimidine to pyrimidine mutation (Fig. <xref rid="Fig7" ref-type="fig">7</xref>).</p>
        <p id="Par49">Finally, tobacco smoking is known to induce GPR15-expressing T cells; although the exact role of GPR15 in response to smoking is yet to be elucidated [<xref ref-type="bibr" rid="CR65">65</xref>]. Therefore, we investigated whether the results of <sc>GeneSigNet</sc> provide additional insights into this relation. Consistently with previous studies, <sc>GeneSigNet</sc> inferred a strong association between GPR15 and SBS4 without resolving the direction (see also Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S4). Next, we analyzed the influence that GPR15 has on other nodes of the GSN network. The results of <sc>GeneSigNet</sc> suggest that GPR15 is involved in the negative regulation of several genes related to chemotaxis, including IL10, a cytokine with potent anti-inflammatory properties, and has a positive impact on lymphocyte migration and leukocyte mediated cytotoxicity (Fig. <xref rid="Fig8" ref-type="fig">8</xref>).<fig id="Fig8"><label>Fig. 8</label><caption><p>Subnetwork of Lung Adenocarcinoma GSN centered on the node representing GPR15 gene. Expression of the GPR15 gene contributes to the activation of immune responses. The meaning of edge and node colors, and boxes is the same as in Figs. <xref rid="Fig1" ref-type="fig">1</xref> and <xref rid="Fig6" ref-type="fig">6</xref>. An extended subnetwork including all MutStates and an extended list of genes is provided as Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S4</p></caption><graphic xlink:href="13073_2023_1162_Fig8_HTML" id="MO8"/></fig></p>
      </sec>
      <sec id="Sec19">
        <title>GeneSigNet points to the role of DNA geometric changes for APOBEC signature SBS2</title>
        <p id="Par50">As discussed earlier, APOBEC can only act on single-stranded DNA (ssDNA). Interestingly, one of the GO terms associated with SBS2 MutState identified by <sc>GeneSigNet</sc> is DNA geometric change (Fig. <xref rid="Fig7" ref-type="fig">7</xref>). DNA geometric changes are local changes of DNA conformation such as bulky DNA adducts (a type of DNA damage due to exposure to cigarette smoke) or DNA secondary structures such as Z-DNA, cruciforms, or quadruplexes. Indeed, these structures often involve the formation of ssDNA regions which, in turn, provide mutation opportunities for APOBEC enzymes [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR68">68</xref>]. The formation of DNA secondary structures is often associated with DNA supercoiling — a form of DNA stress that is resolved by Topoisomerase 1 (TOP1). Interestingly, <sc>GeneSigNet</sc> identified a negative influence of TOP1 expression on one of the genes (XPA) contributing to this GO term. This suggests a relation between DNA stress mediated by TOP1 and APOBEC activity.</p>
      </sec>
    </sec>
  </sec>
  <sec id="Sec20">
    <title>Discussion</title>
    <p id="Par51">Elucidating the nature of mutagenic processes and their interactions with cellular processes is of fundamental importance for understating cancer etiology and guiding cancer therapy. Here, we propose <sc>GeneSigNet</sc>, a new network-based approach that infers the relation between gene expression and the strength of mutation patterns (signature exposures) allowing us to uncover the relations between signatures and processes involved in DNA repair and immune response among other cellular processes. Recognizing the limitations of the previous approaches, <sc>GeneSigNet</sc> relies on a construction of a sparse directed network. For each node (gene or MutState), it selects a sparse set of incoming edges representing dominating incoming effects so that their combination explains the activity of the node. Aiming to capture the most dominant influences, the method utilizes sparse partial correlation coefficients.</p>
    <p id="Par52">In this study we focused on the relations that can be inferred based on genes’ expressions and exposures of mutational signatures. It is possible to include other features as well. We leveraged this flexibility of our method to include for breast cancer germline perturbations that are known to predispose homologous recombination deficiency (HD).</p>
    <p id="Par53">The construction of a sparse network utilized by our approach has both advantages and disadvantages. Sparse networks are easier to interpret and more likely to suggest mechanistic insights. However, by restricting edge set, they might lose some information. In our previous studies [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR69">69</xref>] we have developed a clustering based approach that leverages gene co-expression. These two approaches illustrate the trade-off between a gene-level analysis which has the potential for more mechanistic explanation (e.g., association of Tregs with APOBEC we have identified in this paper) while potentially losing some information and a cluster-level analysis which is empowered by the correlations between expression of genes but provides GO-term interpretability only. In future studies, it could be beneficial to consider a hierarchical representation that can work on many levels of granularity simultaneously, combining the strengths of both approaches.</p>
    <p id="Par54">For the biological results, overall the relations discovered by <sc>GeneSigNet</sc> are consistent with the current knowledge, boosting the confidence in the method’s applicability. In addition, <sc>GeneSigNet</sc> provided several new biological insights concerning the relation between mutagenic processes and other cellular processes. For example, the uncovered relation between APOBEC hypermutation and activation of regulatory T cell can have an important implication in immunotherapy.</p>
  </sec>
  <sec id="Sec21">
    <title>Conclusions</title>
    <p id="Par55">In this work, we report a computational method, named <sc>GeneSigNet</sc>, for uncovering potentially causal relations between gene expression and mutagenic processes represented by mutational signatures. The main idea of the approach is to construct an influence network representing dependency flow between genes and mutational signatures. We opted to infer a sparse network in order to focus on the strongest trends that are more likely to suggest mechanistic explanations. We note that focusing on a sparse set of edges reduces the power of GO enrichment analysis and requires more specific biological knowledge for interpreting the results. Yet, this potential disadvantage is compensated by the compelling mechanistic insights provided by the method.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary information</title>
    <sec id="Sec22">
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="13073_2023_1162_MOESM1_ESM.pdf">
            <caption>
              <p><bold>Additional file 1.</bold> Supplemental Information includes Sections S1, S1.1, S1.2, S1.3, S1.4, and S1.5: detailed descriptions of the <sc>GeneSigNet</sc>, and data simulation schema for validation, Table S1: Supplemental table providing the topological information on the inferred networks, Figs. S1, S2, S3, and S4: Supplemental figures for visualizing the performance of the <sc>GeneSigNet</sc> method and the extended subnetworks covering the mutational signatures and their direct neighbors. (PDF)</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM2">
          <media xlink:href="13073_2023_1162_MOESM2_ESM.xlsx">
            <caption>
              <p><bold>Additional file 2.</bold> Tables S2 (BRCA), and S3 (LUAD) : Supplemental tables providing the genes enriched in up and down streams of mutational signatures and their interaction weights in the gene signature networks of BRCA and LUAD. (Excel)</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM3">
          <media xlink:href="13073_2023_1162_MOESM3_ESM.xlsx">
            <caption>
              <p><bold>Additional file 3.</bold> Tables S4 (BRCA) and S5 (LUAD): Supplemental tables providing the GO terms enriched for causal and affected genes of mutational signatures in the gene signature networks of BRCA and LUAD. (Excel)</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher’s Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
    <fn>
      <p>Yoo-Ah Kim and Teresa M. Przytycka contributed equally to this work.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>We thank Jan Hoinka and Ermin Hodzic for their helpful comments on the manuscript.</p>
    <sec id="FPar1">
      <title>Research conforming to the principles of the Helsinki Declaration</title>
      <p id="Par56">The research does not involve human subjects.</p>
    </sec>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors’ contributions</title>
    <p>BA, YK, and TMP designed the method. BA, YK, and DW prepared the data. BA performed the experiments. All authors wrote the manuscript. TMP supervised the study. All authors read and approved the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>Open Access funding provided by the National Institutes of Health (NIH). This research was supported by the Intramural Research Program of the National Library of Medicine at the National Institutes of Health, USA. DW is currently supported by Polish National Agency for Academic Exchange (Polish Returns Programme, PPN/PPO/2020/1/00028).</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>The <sc>GeneSigNet</sc> method was implemented in python, and installable package, source codes and the data sets used for and generated during this study are available at the Github site <ext-link ext-link-type="uri" xlink:href="https://github.com/ncbi/GeneSigNet">https://github.com/ncbi/GeneSigNet</ext-link> [<xref ref-type="bibr" rid="CR37">37</xref>].</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar2">
      <title>Ethics approval and consent to participate</title>
      <p id="Par57">Not applicable.</p>
    </notes>
    <notes id="FPar3">
      <title>Consent for publication</title>
      <p id="Par58">Not applicable.</p>
    </notes>
    <notes id="FPar4" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par59">The authors declare that they have no competing interests.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Alexandrov</surname>
            <given-names>LB</given-names>
          </name>
          <name>
            <surname>Nik-Zainal</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Wedge</surname>
            <given-names>DC</given-names>
          </name>
          <name>
            <surname>Campbell</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Stratton</surname>
            <given-names>MR</given-names>
          </name>
        </person-group>
        <article-title>Deciphering signatures of mutational processes operative in human cancer</article-title>
        <source>Cell Rep.</source>
        <year>2013</year>
        <volume>3</volume>
        <issue>1</issue>
        <fpage>246</fpage>
        <lpage>259</lpage>
        <pub-id pub-id-type="doi">10.1016/j.celrep.2012.12.008</pub-id>
        <?supplied-pmid 23318258?>
        <pub-id pub-id-type="pmid">23318258</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Alexandrov</surname>
            <given-names>LB</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Haradhvala</surname>
            <given-names>NJ</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>MN</given-names>
          </name>
          <name>
            <surname>Tian Ng</surname>
            <given-names>AW</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The repertoire of mutational signatures in human cancer</article-title>
        <source>Nature.</source>
        <year>2020</year>
        <volume>578</volume>
        <issue>7793</issue>
        <fpage>94</fpage>
        <lpage>101</lpage>
        <pub-id pub-id-type="doi">10.1038/s41586-020-1943-3</pub-id>
        <?supplied-pmid 32025018?>
        <pub-id pub-id-type="pmid">32025018</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>YA</given-names>
          </name>
          <name>
            <surname>Leiserson</surname>
            <given-names>MDM</given-names>
          </name>
          <name>
            <surname>Moorjani</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Sharan</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Wojtowicz</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Przytycka</surname>
            <given-names>TM</given-names>
          </name>
        </person-group>
        <article-title>Mutational Signatures: From Methods to Mechanisms</article-title>
        <source>Annu Rev Biomed Data Sci.</source>
        <year>2021</year>
        <volume>4</volume>
        <fpage>189</fpage>
        <lpage>206</lpage>
        <pub-id pub-id-type="doi">10.1146/annurev-biodatasci-122320-120920</pub-id>
        <?supplied-pmid 34465178?>
        <pub-id pub-id-type="pmid">34465178</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Viel</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bruselles</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Meccia</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Fornasarig</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Quaia</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Canzonieri</surname>
            <given-names>V</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A Specific Mutational Signature Associated with DNA 8-Oxoguanine Persistence in MUTYH-defective Colorectal Cancer</article-title>
        <source>EBioMedicine.</source>
        <year>2017</year>
        <volume>20</volume>
        <fpage>39</fpage>
        <lpage>49</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ebiom.2017.04.022</pub-id>
        <?supplied-pmid 28551381?>
        <pub-id pub-id-type="pmid">28551381</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Mouw</surname>
            <given-names>KW</given-names>
          </name>
          <name>
            <surname>Polak</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Braunstein</surname>
            <given-names>LZ</given-names>
          </name>
          <name>
            <surname>Kamburov</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kwiatkowski</surname>
            <given-names>DJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors</article-title>
        <source>Nat Genet.</source>
        <year>2016</year>
        <volume>48</volume>
        <issue>6</issue>
        <fpage>600</fpage>
        <lpage>606</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.3557</pub-id>
        <?supplied-pmid 27111033?>
        <pub-id pub-id-type="pmid">27111033</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zou</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Owusu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Harris</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Jackson</surname>
            <given-names>SP</given-names>
          </name>
          <name>
            <surname>Loizou</surname>
            <given-names>JI</given-names>
          </name>
          <name>
            <surname>Nik-Zainal</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Validating the concept of mutational signatures with isogenic cell models</article-title>
        <source>Nat Commun.</source>
        <year>2018</year>
        <volume>9</volume>
        <issue>1</issue>
        <fpage>1744</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-018-04052-8</pub-id>
        <?supplied-pmid 29717121?>
        <pub-id pub-id-type="pmid">29717121</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Volinia</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Druck</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Paisie</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Schrock</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Huebner</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles</article-title>
        <source>Oncotarget.</source>
        <year>2017</year>
        <volume>8</volume>
        <issue>60</issue>
        <fpage>102199</fpage>
        <lpage>102211</lpage>
        <pub-id pub-id-type="doi">10.18632/oncotarget.22321</pub-id>
        <?supplied-pmid 29254236?>
        <pub-id pub-id-type="pmid">29254236</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>YA</given-names>
          </name>
          <name>
            <surname>Wojtowicz</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Sarto Basso</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Sason</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Robinson</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Hochbaum</surname>
            <given-names>DS</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Network-based approaches elucidate differences within APOBEC and clock-like signatures in breast cancer</article-title>
        <source>Genome Med.</source>
        <year>2020</year>
        <volume>12</volume>
        <issue>1</issue>
        <fpage>52</fpage>
        <pub-id pub-id-type="doi">10.1186/s13073-020-00745-2</pub-id>
        <?supplied-pmid 32471470?>
        <pub-id pub-id-type="pmid">32471470</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wojtowicz</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Sason</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>YA</given-names>
          </name>
          <name>
            <surname>Leiserson</surname>
            <given-names>MDM</given-names>
          </name>
          <name>
            <surname>Przytycka</surname>
            <given-names>TM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Hidden Markov models lead to higher resolution maps of mutation signature activity in cancer</article-title>
        <source>Genome Med.</source>
        <year>2019</year>
        <volume>11</volume>
        <issue>1</issue>
        <fpage>49</fpage>
        <pub-id pub-id-type="doi">10.1186/s13073-019-0659-1</pub-id>
        <?supplied-pmid 31349863?>
        <pub-id pub-id-type="pmid">31349863</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Alexandrov</surname>
            <given-names>LB</given-names>
          </name>
          <name>
            <surname>Ju</surname>
            <given-names>YS</given-names>
          </name>
          <name>
            <surname>Haase</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Van Loo</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Martincorena</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Nik-Zainal</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Mutational signatures associated with tobacco smoking in human cancer</article-title>
        <source>Science.</source>
        <year>2016</year>
        <volume>354</volume>
        <issue>6312</issue>
        <fpage>618</fpage>
        <lpage>622</lpage>
        <pub-id pub-id-type="doi">10.1126/science.aag0299</pub-id>
        <?supplied-pmid 27811275?>
        <pub-id pub-id-type="pmid">27811275</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wong</surname>
            <given-names>JKL</given-names>
          </name>
          <name>
            <surname>ller</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Schulze</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hlevnjak</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Elgaafary</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lichter</surname>
            <given-names>P</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions</article-title>
        <source>Nat Commun.</source>
        <year>2022</year>
        <volume>13</volume>
        <issue>1</issue>
        <fpage>178</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-021-27792-6</pub-id>
        <?supplied-pmid 35013316?>
        <pub-id pub-id-type="pmid">35013316</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Temko</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Tomlinson</surname>
            <given-names>IPM</given-names>
          </name>
          <name>
            <surname>Severini</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Schuster-Böckler</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Graham</surname>
            <given-names>TA</given-names>
          </name>
        </person-group>
        <article-title>The effects of mutational processes and selection on driver mutations across cancer types</article-title>
        <source>Nat Commun.</source>
        <year>2018</year>
        <volume>9</volume>
        <issue>1</issue>
        <fpage>1857</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-018-04208-6</pub-id>
        <?supplied-pmid 29748584?>
        <pub-id pub-id-type="pmid">29748584</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cook</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Melloni</surname>
            <given-names>GEM</given-names>
          </name>
          <name>
            <surname>Gulhan</surname>
            <given-names>DC</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Haigis</surname>
            <given-names>KM</given-names>
          </name>
        </person-group>
        <article-title>The origins and genetic interactions of KRAS mutations are allele- and tissue-specific</article-title>
        <source>Nat Commun.</source>
        <year>2021</year>
        <volume>12</volume>
        <issue>1</issue>
        <fpage>1808</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-021-22125-z</pub-id>
        <?supplied-pmid 33753749?>
        <pub-id pub-id-type="pmid">33753749</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nowarski</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kotler</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>APOBEC3 cytidine deaminases in double-strand DNA break repair and cancer promotion</article-title>
        <source>Cancer Res.</source>
        <year>2013</year>
        <volume>73</volume>
        <issue>12</issue>
        <fpage>3494</fpage>
        <lpage>3498</lpage>
        <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-13-0728</pub-id>
        <?supplied-pmid 23598277?>
        <pub-id pub-id-type="pmid">23598277</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Silverbush</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Sharan</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Network orientation via shortest paths</article-title>
        <source>Bioinformatics.</source>
        <year>2014</year>
        <volume>30</volume>
        <issue>10</issue>
        <fpage>1449</fpage>
        <lpage>1455</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btu043</pub-id>
        <?supplied-pmid 24470573?>
        <pub-id pub-id-type="pmid">24470573</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gitter</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Klein-Seetharaman</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Gupta</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bar-Joseph</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>Discovering pathways by orienting edges in protein interaction networks</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2011</year>
        <volume>39</volume>
        <issue>4</issue>
        <fpage>e22</fpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkq1207</pub-id>
        <?supplied-pmid 21109539?>
        <pub-id pub-id-type="pmid">21109539</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vinayagam</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Stelzl</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Foulle</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Plassmann</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zenkner</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Timm</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A directed protein interaction network for investigating intracellular signal transduction</article-title>
        <source>Sci Signal.</source>
        <year>2011</year>
        <volume>4</volume>
        <issue>189</issue>
        <fpage>rs8</fpage>
        <pub-id pub-id-type="doi">10.1126/scisignal.2001699</pub-id>
        <?supplied-pmid 21900206?>
        <pub-id pub-id-type="pmid">21900206</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Silverbush</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Sharan</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>A systematic approach to orient the human protein-protein interaction network</article-title>
        <source>Nat Commun.</source>
        <year>2019</year>
        <volume>10</volume>
        <issue>1</issue>
        <fpage>3015</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-019-10887-6</pub-id>
        <?supplied-pmid 31289271?>
        <pub-id pub-id-type="pmid">31289271</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <mixed-citation publication-type="other">Shimizu S, Hoyer P, Hyvärinen A, Kerminen A, Jordan M. A linear non-Gaussian acyclic model for causal discovery. J Mach Learn Res. 2006;7(10):2003–30.</mixed-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Opgen-Rhein</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Strimmer</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>From correlation to causation networks: a simple approximate learning algorithm and its application to high-dimensional plant gene expression data</article-title>
        <source>BMC Syst Biol.</source>
        <year>2007</year>
        <volume>1</volume>
        <fpage>37</fpage>
        <pub-id pub-id-type="doi">10.1186/1752-0509-1-37</pub-id>
        <?supplied-pmid 17683609?>
        <pub-id pub-id-type="pmid">17683609</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Amgalan</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>DEOD: uncovering dominant effects of cancer-driver genes based on a partial covariance selection method</article-title>
        <source>Bioinformatics.</source>
        <year>2015</year>
        <volume>31</volume>
        <issue>15</issue>
        <fpage>2452</fpage>
        <lpage>2460</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btv175</pub-id>
        <?supplied-pmid 25819079?>
        <pub-id pub-id-type="pmid">25819079</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dodge</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yadegari</surname>
            <given-names>I</given-names>
          </name>
        </person-group>
        <article-title>On direction of dependence</article-title>
        <source>Metrika.</source>
        <year>2010</year>
        <volume>72</volume>
        <issue>1</issue>
        <fpage>139</fpage>
        <pub-id pub-id-type="doi">10.1007/s00184-009-0273-0</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <mixed-citation publication-type="other">Moretton A, Loizou JI. Interplay between Cellular Metabolism and the DNA Damage Response in Cancer. Cancers (Basel). 2020;12(8):2051.</mixed-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nakad</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Schumacher</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>DNA Damage Response and Immune Defense: Links and Mechanisms</article-title>
        <source>Front Genet.</source>
        <year>2016</year>
        <volume>7</volume>
        <fpage>147</fpage>
        <pub-id pub-id-type="doi">10.3389/fgene.2016.00147</pub-id>
        <?supplied-pmid 27555866?>
        <pub-id pub-id-type="pmid">27555866</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jager</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Blokzijl</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Kuijk</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Bertl</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Vougioukalaki</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Janssen</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Deficiency of nucleotide excision repair is associated with mutational signature observed in cancer</article-title>
        <source>Genome Res.</source>
        <year>2019</year>
        <volume>29</volume>
        <issue>7</issue>
        <fpage>1067</fpage>
        <lpage>1077</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.246223.118</pub-id>
        <?supplied-pmid 31221724?>
        <pub-id pub-id-type="pmid">31221724</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <mixed-citation publication-type="other">Fujikoshi Y, Ulyanov VV. Shimizu R. Multivariate statistics: High-dimensional and large-sample approximations. Book. 2011;187–210.</mixed-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lachmann</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Krishnan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Berger</surname>
            <given-names>SI</given-names>
          </name>
          <name>
            <surname>Mazloom</surname>
            <given-names>AR</given-names>
          </name>
          <name>
            <surname>Ma’ayan</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments</article-title>
        <source>Bioinformatics.</source>
        <year>2010</year>
        <volume>26</volume>
        <issue>19</issue>
        <fpage>2438</fpage>
        <lpage>2444</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btq466</pub-id>
        <?supplied-pmid 20709693?>
        <pub-id pub-id-type="pmid">20709693</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sinkhorn</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Knopp</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Concerning nonnegative matrices and doubly stochastic matrices</article-title>
        <source>Pac J Math.</source>
        <year>1967</year>
        <volume>21</volume>
        <issue>2</issue>
        <fpage>343</fpage>
        <lpage>348</lpage>
        <pub-id pub-id-type="doi">10.2140/pjm.1967.21.343</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nik-Zainal</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Davies</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Staaf</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ramakrishna</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Glodzik</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Zou</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences</article-title>
        <source>Nature.</source>
        <year>2019</year>
        <volume>566</volume>
        <issue>7742</issue>
        <fpage>E1</fpage>
        <pub-id pub-id-type="doi">10.1038/s41586-019-0883-2</pub-id>
        <?supplied-pmid 30659290?>
        <pub-id pub-id-type="pmid">30659290</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <mixed-citation publication-type="other">ICGC data portal. <ext-link ext-link-type="uri" xlink:href="https://dcc.icgc.org">https://dcc.icgc.org</ext-link>. Accessed on 1 May 2020.</mixed-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <mixed-citation publication-type="other">COSMIC v2 signature. <ext-link ext-link-type="uri" xlink:href="https://cancer.sanger.ac.uk/cosmic/signature">https://cancer.sanger.ac.uk/cosmic/signature</ext-link>. Accessed on 1 May 2020.</mixed-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Davies</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Glodzik</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Morganella</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yates</surname>
            <given-names>LR</given-names>
          </name>
          <name>
            <surname>Staaf</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zou</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures</article-title>
        <source>Nat Med.</source>
        <year>2017</year>
        <volume>23</volume>
        <issue>4</issue>
        <fpage>517</fpage>
        <lpage>525</lpage>
        <pub-id pub-id-type="doi">10.1038/nm.4292</pub-id>
        <?supplied-pmid 28288110?>
        <pub-id pub-id-type="pmid">28288110</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <mixed-citation publication-type="other">Data Commons Data Portal. <ext-link ext-link-type="uri" xlink:href="https://portal.gdc.cancer.gov">https://portal.gdc.cancer.gov</ext-link>. Accessed on 1 May 2020.</mixed-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <mixed-citation publication-type="other">Synapse data portal. <ext-link ext-link-type="uri" xlink:href="https://www.synapse.org/#!Synapse:syn11801889">https://www.synapse.org/#!Synapse:syn11801889</ext-link>. Accessed on 1 May 2020.</mixed-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Wojtowicz</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Przytycka</surname>
            <given-names>TM</given-names>
          </name>
        </person-group>
        <article-title>Detecting presence of mutational signatures in cancer with confidence</article-title>
        <source>Bioinformatics.</source>
        <year>2018</year>
        <volume>34</volume>
        <issue>2</issue>
        <fpage>330</fpage>
        <lpage>337</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btx604</pub-id>
        <?supplied-pmid 29028923?>
        <pub-id pub-id-type="pmid">29028923</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <mixed-citation publication-type="other">Synapse data portal. <ext-link ext-link-type="uri" xlink:href="https://www.synapse.org/#!Synapse:syn11804065">https://www.synapse.org/#!Synapse:syn11804065</ext-link>. Accessed on 1 May 2020.</mixed-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <mixed-citation publication-type="other">Amgalan A. A network-based approach to infer causality flows among genes and mutational signatures. Github. 2022. <ext-link ext-link-type="uri" xlink:href="https://github.com/ncbi/GeneSigNet">https://github.com/ncbi/GeneSigNet</ext-link>. Accessed on 12 Nov 2022.</mixed-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zou</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Hastie</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Regularization and variable selection via the elastic net</article-title>
        <source>J R Stat Soc Ser B (Stat Methodol).</source>
        <year>2005</year>
        <volume>67</volume>
        <issue>2</issue>
        <fpage>301</fpage>
        <lpage>320</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1467-9868.2005.00503.x</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <mixed-citation publication-type="other">Huynh-Thu VA, Irrthum A, Wehenkel L, Geurts P. Inferring regulatory networks from expression data using tree-based methods. PLoS ONE. 2010;5(9): e12776.</mixed-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Thieffry</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Cantini</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Evaluating the Reproducibility of Single-Cell Gene Regulatory Network Inference Algorithms</article-title>
        <source>Front Genet.</source>
        <year>2021</year>
        <volume>12</volume>
        <fpage>617282</fpage>
        <pub-id pub-id-type="doi">10.3389/fgene.2021.617282</pub-id>
        <?supplied-pmid 33828580?>
        <pub-id pub-id-type="pmid">33828580</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huynh-Thu</surname>
            <given-names>VA</given-names>
          </name>
          <name>
            <surname>Geurts</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>dynGENIE3: dynamical GENIE3 for the inference of gene networks from time series expression data</article-title>
        <source>Sci Rep.</source>
        <year>2018</year>
        <volume>8</volume>
        <issue>1</issue>
        <fpage>3384</fpage>
        <pub-id pub-id-type="doi">10.1038/s41598-018-21715-0</pub-id>
        <?supplied-pmid 29467401?>
        <pub-id pub-id-type="pmid">29467401</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <mixed-citation publication-type="other">Marbach D, Costello JC, Küffner R, Vega NM, Prill RJ, Camacho DM, et al. "Wisdom of crowds for robust gene network inference." Nat Methods. 2012; 9(8):796–804.</mixed-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Supek</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Lehner</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>Clustered Mutation Signatures Reveal that Error-Prone DNA Repair Targets Mutations to Active Genes</article-title>
        <source>Cell.</source>
        <year>2017</year>
        <volume>170</volume>
        <issue>3</issue>
        <fpage>534</fpage>
        <lpage>547</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2017.07.003</pub-id>
        <?supplied-pmid 28753428?>
        <pub-id pub-id-type="pmid">28753428</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mas-Ponte</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Supek</surname>
            <given-names>F</given-names>
          </name>
        </person-group>
        <article-title>DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers</article-title>
        <source>Nat Genet.</source>
        <year>2020</year>
        <volume>52</volume>
        <issue>9</issue>
        <fpage>958</fpage>
        <lpage>968</lpage>
        <pub-id pub-id-type="doi">10.1038/s41588-020-0674-6</pub-id>
        <?supplied-pmid 32747826?>
        <pub-id pub-id-type="pmid">32747826</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Taylor</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Nik-Zainal</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>YL</given-names>
          </name>
          <name>
            <surname>Stebbings</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Raine</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Campbell</surname>
            <given-names>PJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis</article-title>
        <source>Elife.</source>
        <year>2013</year>
        <volume>2</volume>
        <fpage>e00534</fpage>
        <pub-id pub-id-type="doi">10.7554/eLife.00534</pub-id>
        <?supplied-pmid 23599896?>
        <pub-id pub-id-type="pmid">23599896</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Prakash</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Jasin</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins</article-title>
        <source>Cold Spring Harb Perspect Biol.</source>
        <year>2015</year>
        <volume>7</volume>
        <issue>4</issue>
        <fpage>a016600</fpage>
        <pub-id pub-id-type="doi">10.1101/cshperspect.a016600</pub-id>
        <?supplied-pmid 25833843?>
        <pub-id pub-id-type="pmid">25833843</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Moynahan</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Jasin</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis</article-title>
        <source>Nat Rev Mol Cell Biol.</source>
        <year>2010</year>
        <volume>11</volume>
        <issue>3</issue>
        <fpage>196</fpage>
        <lpage>207</lpage>
        <pub-id pub-id-type="doi">10.1038/nrm2851</pub-id>
        <?supplied-pmid 20177395?>
        <pub-id pub-id-type="pmid">20177395</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Heyer</surname>
            <given-names>WD</given-names>
          </name>
        </person-group>
        <article-title>Homologous recombination in DNA repair and DNA damage tolerance</article-title>
        <source>Cell Res.</source>
        <year>2008</year>
        <volume>18</volume>
        <issue>1</issue>
        <fpage>99</fpage>
        <lpage>113</lpage>
        <pub-id pub-id-type="doi">10.1038/cr.2008.1</pub-id>
        <?supplied-pmid 18166982?>
        <pub-id pub-id-type="pmid">18166982</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Seplyarskiy</surname>
            <given-names>VB</given-names>
          </name>
          <name>
            <surname>Soldatov</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Popadin</surname>
            <given-names>KY</given-names>
          </name>
          <name>
            <surname>Antonarakis</surname>
            <given-names>SE</given-names>
          </name>
          <name>
            <surname>Bazykin</surname>
            <given-names>GA</given-names>
          </name>
          <name>
            <surname>Nikolaev</surname>
            <given-names>SI</given-names>
          </name>
        </person-group>
        <article-title>APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication</article-title>
        <source>Genome Res.</source>
        <year>2016</year>
        <volume>26</volume>
        <issue>2</issue>
        <fpage>174</fpage>
        <lpage>182</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.197046.115</pub-id>
        <?supplied-pmid 26755635?>
        <pub-id pub-id-type="pmid">26755635</pub-id>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kanu</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Cerone</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Goh</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Zalmas</surname>
            <given-names>LP</given-names>
          </name>
          <name>
            <surname>Bartkova</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Dietzen</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer</article-title>
        <source>Genome Biol.</source>
        <year>2016</year>
        <volume>17</volume>
        <issue>1</issue>
        <fpage>185</fpage>
        <pub-id pub-id-type="doi">10.1186/s13059-016-1042-9</pub-id>
        <?supplied-pmid 27634334?>
        <pub-id pub-id-type="pmid">27634334</pub-id>
      </element-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sakofsky</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Saini</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Klimczak</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Chan</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Malc</surname>
            <given-names>EP</given-names>
          </name>
          <name>
            <surname>Mieczkowski</surname>
            <given-names>PA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Repair of multiple simultaneous double-strand breaks causes bursts of genome-wide clustered hypermutation</article-title>
        <source>PLoS Biol.</source>
        <year>2019</year>
        <volume>17</volume>
        <issue>9</issue>
        <fpage>e3000464</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pbio.3000464</pub-id>
        <?supplied-pmid 31568516?>
        <pub-id pub-id-type="pmid">31568516</pub-id>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chan</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Gordenin</surname>
            <given-names>DA</given-names>
          </name>
        </person-group>
        <article-title>Clusters of Multiple Mutations: Incidence and Molecular Mechanisms</article-title>
        <source>Annu Rev Genet.</source>
        <year>2015</year>
        <volume>49</volume>
        <fpage>243</fpage>
        <lpage>267</lpage>
        <pub-id pub-id-type="doi">10.1146/annurev-genet-112414-054714</pub-id>
        <?supplied-pmid 26631512?>
        <pub-id pub-id-type="pmid">26631512</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Facciabene</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Motz</surname>
            <given-names>GT</given-names>
          </name>
          <name>
            <surname>Coukos</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>T-regulatory cells: key players in tumor immune escape and angiogenesis</article-title>
        <source>Cancer Res.</source>
        <year>2012</year>
        <volume>72</volume>
        <issue>9</issue>
        <fpage>2162</fpage>
        <lpage>2171</lpage>
        <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-11-3687</pub-id>
        <?supplied-pmid 22549946?>
        <pub-id pub-id-type="pmid">22549946</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rudensky</surname>
            <given-names>AY</given-names>
          </name>
        </person-group>
        <article-title>Regulatory T cells and Foxp3</article-title>
        <source>Immunol Rev.</source>
        <year>2011</year>
        <volume>241</volume>
        <issue>1</issue>
        <fpage>260</fpage>
        <lpage>268</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1600-065X.2011.01018.x</pub-id>
        <?supplied-pmid 21488902?>
        <pub-id pub-id-type="pmid">21488902</pub-id>
      </element-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chung</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Tanaka</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Chu</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Nurieva</surname>
            <given-names>RI</given-names>
          </name>
          <name>
            <surname>Martinez</surname>
            <given-names>GJ</given-names>
          </name>
          <name>
            <surname>Rawal</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions</article-title>
        <source>Nat Med.</source>
        <year>2011</year>
        <volume>17</volume>
        <issue>8</issue>
        <fpage>983</fpage>
        <lpage>988</lpage>
        <pub-id pub-id-type="doi">10.1038/nm.2426</pub-id>
        <?supplied-pmid 21785430?>
        <pub-id pub-id-type="pmid">21785430</pub-id>
      </element-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>HM</given-names>
          </name>
          <name>
            <surname>van der Touw</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>YS</given-names>
          </name>
          <name>
            <surname>Kang</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Mai</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity</article-title>
        <source>J Clin Invest.</source>
        <year>2018</year>
        <volume>128</volume>
        <issue>12</issue>
        <fpage>5647</fpage>
        <lpage>5662</lpage>
        <pub-id pub-id-type="doi">10.1172/JCI97570</pub-id>
        <?supplied-pmid 30352428?>
        <pub-id pub-id-type="pmid">30352428</pub-id>
      </element-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sholl</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Hirsch</surname>
            <given-names>FR</given-names>
          </name>
          <name>
            <surname>Hwang</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Botling</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lopez-Rios</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Bubendorf</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee</article-title>
        <source>J Thorac Oncol.</source>
        <year>2020</year>
        <volume>15</volume>
        <issue>9</issue>
        <fpage>1409</fpage>
        <lpage>1424</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jtho.2020.05.019</pub-id>
        <?supplied-pmid 32522712?>
        <pub-id pub-id-type="pmid">32522712</pub-id>
      </element-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jia</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>XS</given-names>
          </name>
        </person-group>
        <article-title>APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer</article-title>
        <source>Oncogene.</source>
        <year>2018</year>
        <volume>37</volume>
        <issue>29</issue>
        <fpage>3924</fpage>
        <lpage>3936</lpage>
        <pub-id pub-id-type="doi">10.1038/s41388-018-0245-9</pub-id>
        <?supplied-pmid 29695832?>
        <pub-id pub-id-type="pmid">29695832</pub-id>
      </element-citation>
    </ref>
    <ref id="CR59">
      <label>59.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Faden</surname>
            <given-names>DL</given-names>
          </name>
          <name>
            <surname>Ding</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhai</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kuo</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Chan</surname>
            <given-names>TA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>APOBEC mutagenesis is tightly linked to the immune landscape and immunotherapy biomarkers in head and neck squamous cell carcinoma</article-title>
        <source>Oral Oncol.</source>
        <year>2019</year>
        <volume>96</volume>
        <fpage>140</fpage>
        <lpage>147</lpage>
        <pub-id pub-id-type="doi">10.1016/j.oraloncology.2019.07.020</pub-id>
        <?supplied-pmid 31422205?>
        <pub-id pub-id-type="pmid">31422205</pub-id>
      </element-citation>
    </ref>
    <ref id="CR60">
      <label>60.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chan</surname>
            <given-names>TA</given-names>
          </name>
          <name>
            <surname>Yarchoan</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Jaffee</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Swanton</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Quezada</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Stenzinger</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic</article-title>
        <source>Ann Oncol.</source>
        <year>2019</year>
        <volume>30</volume>
        <issue>1</issue>
        <fpage>44</fpage>
        <lpage>56</lpage>
        <pub-id pub-id-type="doi">10.1093/annonc/mdy495</pub-id>
        <?supplied-pmid 30395155?>
        <pub-id pub-id-type="pmid">30395155</pub-id>
      </element-citation>
    </ref>
    <ref id="CR61">
      <label>61.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Venkatesan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rosenthal</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kanu</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>McGranahan</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Bartek</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Quezada</surname>
            <given-names>SA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution</article-title>
        <source>Ann Oncol.</source>
        <year>2018</year>
        <volume>29</volume>
        <issue>3</issue>
        <fpage>563</fpage>
        <lpage>572</lpage>
        <pub-id pub-id-type="doi">10.1093/annonc/mdy003</pub-id>
        <?supplied-pmid 29324969?>
        <pub-id pub-id-type="pmid">29324969</pub-id>
      </element-citation>
    </ref>
    <ref id="CR62">
      <label>62.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Saleh</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Elkord</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Treg-mediated acquired resistance to immune checkpoint inhibitors</article-title>
        <source>Cancer Lett.</source>
        <year>2019</year>
        <volume>457</volume>
        <fpage>168</fpage>
        <lpage>179</lpage>
        <pub-id pub-id-type="doi">10.1016/j.canlet.2019.05.003</pub-id>
        <?supplied-pmid 31078738?>
        <pub-id pub-id-type="pmid">31078738</pub-id>
      </element-citation>
    </ref>
    <ref id="CR63">
      <label>63.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Principe</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Chiec</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Mohindra</surname>
            <given-names>NA</given-names>
          </name>
          <name>
            <surname>Munshi</surname>
            <given-names>HG</given-names>
          </name>
        </person-group>
        <article-title>Regulatory T-Cells as an Emerging Barrier to Immune Checkpoint Inhibition in Lung Cancer</article-title>
        <source>Front Oncol.</source>
        <year>2021</year>
        <volume>11</volume>
        <fpage>684098</fpage>
        <pub-id pub-id-type="doi">10.3389/fonc.2021.684098</pub-id>
        <?supplied-pmid 34141625?>
        <pub-id pub-id-type="pmid">34141625</pub-id>
      </element-citation>
    </ref>
    <ref id="CR64">
      <label>64.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Patriarca</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Foege</surname>
            <given-names>WH</given-names>
          </name>
          <name>
            <surname>Swartz</surname>
            <given-names>TA</given-names>
          </name>
        </person-group>
        <article-title>Progress in polio eradication</article-title>
        <source>Lancet.</source>
        <year>1993</year>
        <volume>342</volume>
        <issue>8885</issue>
        <fpage>1461</fpage>
        <lpage>1464</lpage>
        <pub-id pub-id-type="doi">10.1016/0140-6736(93)92936-N</pub-id>
        <?supplied-pmid 7902485?>
        <pub-id pub-id-type="pmid">7902485</pub-id>
      </element-citation>
    </ref>
    <ref id="CR65">
      <label>65.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kõks</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kõks</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Activation of GPR15 and its involvement in the biological effects of smoking</article-title>
        <source>Exp Biol Med (Maywood).</source>
        <year>2017</year>
        <volume>242</volume>
        <issue>11</issue>
        <fpage>1207</fpage>
        <lpage>1212</lpage>
        <pub-id pub-id-type="doi">10.1177/1535370217703977</pub-id>
        <?supplied-pmid 28423922?>
        <pub-id pub-id-type="pmid">28423922</pub-id>
      </element-citation>
    </ref>
    <ref id="CR66">
      <label>66.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kouzine</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Wojtowicz</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Baranello</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Yamane</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Nelson</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Resch</surname>
            <given-names>W</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Permanganate/S1 Nuclease Footprinting Reveals Non-B DNA Structures with Regulatory Potential across a Mammalian Genome</article-title>
        <source>Cell Syst.</source>
        <year>2017</year>
        <volume>4</volume>
        <issue>3</issue>
        <fpage>344</fpage>
        <lpage>356</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cels.2017.01.013</pub-id>
        <?supplied-pmid 28237796?>
        <pub-id pub-id-type="pmid">28237796</pub-id>
      </element-citation>
    </ref>
    <ref id="CR67">
      <label>67.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zou</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Morganella</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Glodzik</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Davies</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Stratton</surname>
            <given-names>MR</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Short inverted repeats contribute to localized mutability in human somatic cells</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2017</year>
        <volume>45</volume>
        <issue>19</issue>
        <fpage>11213</fpage>
        <lpage>11221</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkx731</pub-id>
        <?supplied-pmid 28977645?>
        <pub-id pub-id-type="pmid">28977645</pub-id>
      </element-citation>
    </ref>
    <ref id="CR68">
      <label>68.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Guiblet</surname>
            <given-names>WM</given-names>
          </name>
          <name>
            <surname>Cremona</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Harris</surname>
            <given-names>RS</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Eckert</surname>
            <given-names>KA</given-names>
          </name>
          <name>
            <surname>Chiaromonte</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Non-B DNA: a major contributor to small- and large-scale variation in nucleotide substitution frequencies across the genome</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2021</year>
        <volume>49</volume>
        <issue>3</issue>
        <fpage>1497</fpage>
        <lpage>1516</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa1269</pub-id>
        <?supplied-pmid 33450015?>
        <pub-id pub-id-type="pmid">33450015</pub-id>
      </element-citation>
    </ref>
    <ref id="CR69">
      <label>69.</label>
      <mixed-citation publication-type="other">Kim YA, Hodzic E, Amgalan B, Saslafsky A, Wojtowicz D, Przytycka TM. Mutational Signatures as Sensors of Environmental Exposures: Analysis of Smoking-Induced Lung Tissue Remodeling. Biomolecules. 2022;12(10):1384–13.</mixed-citation>
    </ref>
  </ref-list>
</back>
